These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9419581)

  • 1. Neutron capture therapy with gadopentetate dimeglumine: experiments on tumor-bearing rats.
    Khokhlov VF; Yashkin PN; Silin DI; Djorova ES; Lawaczeck R
    Acad Radiol; 1995 May; 2(5):392-8. PubMed ID: 9419581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadolinium neutron capture therapy (GdNCT) of melanoma cells and solid tumors with the magnetic resonance imaging contrast agent Gadobutrol.
    Hofmann B; Fischer CO; Lawaczeck R; Platzek J; Semmler W
    Invest Radiol; 1999 Feb; 34(2):126-33. PubMed ID: 9951792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evaluation of neutron capture therapy effectivity using calcium phosphate-based nanoparticles as Gd-DTPA delivery agent.
    Dewi N; Mi P; Yanagie H; Sakurai Y; Morishita Y; Yanagawa M; Nakagawa T; Shinohara A; Matsukawa T; Yokoyama K; Cabral H; Suzuki M; Sakurai Y; Tanaka H; Ono K; Nishiyama N; Kataoka K; Takahashi H
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):767-75. PubMed ID: 26650198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
    Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor.
    Tokumitsu H; Hiratsuka J; Sakurai Y; Kobayashi T; Ichikawa H; Fukumori Y
    Cancer Lett; 2000 Mar; 150(2):177-82. PubMed ID: 10704740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular uptake and in vitro antitumor efficacy of composite liposomes for neutron capture therapy.
    Peters T; Grunewald C; Blaickner M; Ziegner M; Schütz C; Iffland D; Hampel G; Nawroth T; Langguth P
    Radiat Oncol; 2015 Feb; 10():52. PubMed ID: 25889824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo gadolinium neutron capture therapy using a potentially effective compound (Gd-BOPTA).
    Matsumura A; Zhang T; Yamamoto T; Yoshida F; Sakurai Y; Shimojo N; Nose T
    Anticancer Res; 2003; 23(3B):2451-6. PubMed ID: 12894527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadolinium as a neutron capture therapy agent.
    Shih JL; Brugger RM
    Med Phys; 1992; 19(3):733-44. PubMed ID: 1508113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization.
    Tokumitsu H; Ichikawa H; Fukumori Y
    Pharm Res; 1999 Dec; 16(12):1830-5. PubMed ID: 10644070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo measurement of gadolinium concentration in a rat glioma model by monochromatic quantitative computed tomography: comparison between gadopentetate dimeglumine and gadobutrol.
    Le Duc G; Corde S; Charvet AM; Elleaume H; Farion R; Le Bas JF; Estève F
    Invest Radiol; 2004 Jul; 39(7):385-93. PubMed ID: 15194909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU; Reiser MF; Huber AM
    Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of MRI contrast agents in malignant fibrous histiocytoma for gadolinium neutron capture therapy.
    Fujimoto T; Ichikawa H; Akisue T; Fujita I; Kishimoto K; Hara H; Imabori M; Kawamitsu H; Sharma P; Brown SC; Moudgil BM; Fujii M; Yamamoto T; Kurosaka M; Fukumori Y
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S355-8. PubMed ID: 19386506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hemodynamic effects of recently developed monomer and dimer magnetic resonance imaging contrast media: a comparative study.
    Geschwind JF; Saeed M; Wendland MF; Szolar D; Derugin N; Higgins CB
    Acad Radiol; 1996 Aug; 3(8):667-77. PubMed ID: 8796731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are gadolinium contrast agents suitable for gadolinium neutron capture therapy?
    De Stasio G; Rajesh D; Casalbore P; Daniels MJ; Erhardt RJ; Frazer BH; Wiese LM; Richter KL; Sonderegger BR; Gilbert B; Schaub S; Cannara RJ; Crawford JF; Gilles MK; Tyliszczak T; Fowler JF; Larocca LM; Howard SP; Mercanti D; Mehta MP; Pallini R
    Neurol Res; 2005 Jun; 27(4):387-98. PubMed ID: 15949236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and preparation of ethyl cellulose microcapsules of gadopentetate dimeglumine for neutron-capture therapy using the Wurster process.
    Fukumori Y; Ichikawa H; Tokumitsu H; Miyamoto M; Jono K; Kanamori R; Akine Y; Tokita N
    Chem Pharm Bull (Tokyo); 1993 Jun; 41(6):1144-8. PubMed ID: 8370113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor imaging with a macromolecular paramagnetic contrast agent: gadopentetate dimeglumine-polylysine.
    Opsahl LR; Uzgiris EE; Vera DR
    Acad Radiol; 1995 Sep; 2(9):762-7. PubMed ID: 9419637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadolinium Neutron Capture Therapy for Cats and Dogs with Spontaneous Tumors Using Gd-DTPA.
    Kanygin V; Zaboronok A; Kichigin A; Petrova E; Guselnikova T; Kozlov A; Lukichev D; Mathis BJ; Taskaev S
    Vet Sci; 2023 Apr; 10(4):. PubMed ID: 37104429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T.
    Attenberger UI; Runge VM; Jackson CB; Baumann S; Birkemeier K; Michaely HJ; Schoenberg SO; Reiser MF; Wintersperger BJ
    Invest Radiol; 2009 May; 44(5):251-6. PubMed ID: 19550376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose gadobenate dimeglumine versus standard dose gadopentetate dimeglumine for contrast-enhanced magnetic resonance imaging of the liver: an intra-individual crossover comparison.
    Schneider G; Maas R; Schultze Kool L; Rummeny E; Gehl HB; Lodemann KP; Kirchin MA
    Invest Radiol; 2003 Feb; 38(2):85-94. PubMed ID: 12544071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor angiography using high-resolution, three-dimensional magnetic resonance imaging: comparison of gadopentetate dimeglumine and a macromolecular blood-pool contrast agent.
    Schwickert HC; Stiskal M; van Dijke CF; Roberts TP; Mann JS; Demsar F; Brasch RC
    Acad Radiol; 1995 Oct; 2(10):851-8. PubMed ID: 9419650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.